Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, No 146, South Gandhi Ave, Vanak Sq., P.O.BOX: 1517964311, Tehran, Iran.
Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Fam Cancer. 2022 Apr;21(2):137-142. doi: 10.1007/s10689-021-00242-4. Epub 2021 Mar 23.
BRCA1 and BRCA2 are two prominent genes that account for about 20-40% of inherited breast cancer. Mutations in these genes are often associated with clustering of especially early-onset cancers in the family. The spectrum of BRCA variants showed a significant difference between geographic regions and ethnicities. The frequency and spectrum of BRCA mutations in Iran, a country in southwest Asia, have not yet been thoroughly studied. Here, for the first time, all published and not published BRCA pathogenic variants are presented. Among 1040 high risk families (1258 cases) which were detected, 116 families were found to carry pathogenic variants in either BRCA1 or BRCA2. Altogether 89 distinct types of pathogenic variants have been detected in Iran, including 41 in BRCA1 and 48 in BRCA2. 16 out of 89 mutations had not been previously reported in Iran and are presented for the first time in this article, among which 4 mutations are novel worldwide. 20% of families had one of the seven most commonly observed mutations, including c.81-1G > C, c.66_67delAG, c.4609C>T, c.1568delT, c.1961delA, in BRCA1 and: c.3751_3752insA, c.8585dupT in BRCA2. Combining the data from published articles and our study which has not been published before, a comprehensive table is created as a reference for entire BRCA pathogenic variants and their frequencies in Iran.
BRCA1 和 BRCA2 是两个重要的基因,它们约占遗传性乳腺癌的 20-40%。这些基因的突变通常与家族中特别早发性癌症的聚集有关。BRCA 变体的谱在地理区域和种族之间存在显著差异。亚洲西南部的伊朗尚未对 BRCA 突变的频率和谱进行全面研究。在这里,首次呈现了所有已发表和未发表的 BRCA 致病性变体。在检测到的 1040 个高危家族(1258 例)中,发现 116 个家族在 BRCA1 或 BRCA2 中携带致病性变体。在伊朗共检测到 89 种不同类型的致病性变体,其中 BRCA1 中有 41 种,BRCA2 中有 48 种。在伊朗以前没有报道过 89 个突变中的 16 个,本文首次报道,其中 4 个突变是全球范围内新发现的。20%的家族携带七种最常见突变中的一种,包括 BRCA1 中的 c.81-1G>C、c.66_67delAG、c.4609C>T、c.1568delT、c.1961delA 和 BRCA2 中的 c.3751_3752insA、c.8585dupT。将已发表文章和我们以前未发表的研究数据结合起来,创建了一个全面的表格,作为伊朗整个 BRCA 致病性变体及其频率的参考。